Fund Holdings — Atle Fund Management AB

Total Portfolio Value:
$313.44M
Total Bought:
$188.52M
Total Sold:
$95.28M
Net Transaction:
+$93.24M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)37,24431,133-6,111$3.02M$33.46M10.67%+$30.44M
AbbVie Inc.(ABBV)92,105108,181+16,076$2.26M$24.72M7.89%+$22.45M
Merck & Co., Inc.(MRK)160,913195,768+34,855$1.43M$20.61M6.57%+$19.17M
Thermo Fisher Scientific Inc.(TMO)27,14729,915+2,768$1.40M$17.33M5.53%+$15.94M
Neurocrine Biosciences, Inc.(NBIX)102,62594,796-7,829$1.53M$13.44M4.29%+$11.92M
Intuitive Surgical, Inc.(ISRG)19,70722,322+2,615$935.7K$12.64M4.03%+$11.71M
BeOne Medicines AGADS(ONC)30,33340,432+10,099$1.10M$12.28M3.92%+$11.19M
BridgeBio Pharma, Inc.(BBIO)174,722141,296-33,426$963.4K$10.81M3.45%+$9.84M
Vertex Pharmaceuticals Incorporated(VRTX)17,76622,984+5,218$738.7K$10.42M3.32%+$9.68M
Boston Scientific Corporation(BSX)86,680108,682+22,002$898.4K$10.36M3.31%+$9.46M
Stryker Corporation(SYK)22,76926,835+4,066$893.6K$9.43M3.01%+$8.54M
CVS Health Corporation(CVS)0106,518+106,518$0$8.45M2.70%+$8.45M
Krystal Biotech, Inc.(KRYS)42,19133,853-8,338$790.7K$8.35M2.66%+$7.56M
Cencora Inc28,60823,773-4,835$949.2K$8.03M2.56%+$7.08M
Ionis Pharmaceuticals, Inc.(IONS)092,377+92,377$0$7.31M2.33%+$7.31M
Revolution Medicines, Inc.(RVMD)85,35590,184+4,829$423.2K$7.18M2.29%+$6.76M
Amgen Inc.(AMGN)13,80621,903+8,097$413.6K$7.17M2.29%+$6.76M
Mirum Pharmaceuticals, Inc.(MIRM)93,60589,685-3,920$728.5K$7.08M2.26%+$6.36M
Incyte Corporation(INCY)070,851+70,851$0$7.00M2.23%+$7.00M
NewAmsterdam Pharma Co NV
ORDINARY SHARES
193,625197,036+3,411$584.6K$6.91M2.21%+$6.33M
Alkermes plcSHS(ALKS)252,875242,473-10,402$805.4K$6.78M2.16%+$5.98M
iRhythm Holdings, Inc.(IRTC)29,99137,579+7,588$547.6K$6.67M2.13%+$6.12M
Gilead Sciences, Inc.(GILD)78,16950,796-27,373$921.2K$6.23M1.99%+$5.31M
UFP Technologies, Inc.(UFPT)22,98622,9860$487.1K$5.10M1.63%+$4.62M
Insmed Incorporated(INSM)027,873+27,873$0$4.85M1.55%+$4.85M
Cardinal Health, Inc.(CAH)30,29723,470-6,827$504.9K$4.82M1.54%+$4.32M
ABIVAX Société AnonymeADS(ABVX)031,590+31,590$0$4.26M1.36%+$4.26M
Celcuity Inc.(CELC)37,15741,831+4,674$194.9K$4.17M1.33%+$3.98M
Disc Medicine, Inc.(IRON)45,69047,967+2,277$320.5K$3.81M1.22%+$3.49M
IDEAYA Biosciences, Inc.(IDYA)097,438+97,438$0$3.37M1.07%+$3.37M
UnitedHealth Group Incorporated(UNH)13,72714,636+909$297.9K$3.19M1.02%+$2.89M
Compass Therapeutics, Inc.(CMPX)0584,332+584,332$0$3.14M1.00%+$3.14M
Soleno Therapeutics Inc60,15662,735+2,579$431.7K$2.90M0.93%+$2.47M
Arcellx Inc
COMMON STOCK
25,73241,717+15,985$224.3K$2.72M0.87%+$2.50M
DexCom, Inc.(DXCM)50,87239,722-11,150$363.4K$2.64M0.84%+$2.27M
Autolus Therapeutics plcADS(AUTL)1,169,6341,169,6340$202.4K$2.33M0.74%+$2.13M
Bicara Therapeutics Inc203,755111,363-92,392$341.6K$1.87M0.60%+$1.53M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)175,582107,255-68,327$235.8K$873.1K0.28%+$637.3K
Pyxis Oncology, Inc.(PYXS)0617,245+617,245$0$709.8K0.23%+$709.8K
Avidity Biosciences Inc51,9780-51,978$240.4K$0—-$240.4K
Edwards Lifesciences Corp65,6590-65,659$542.1K$0—-$542.1K
Harmony Biosciences Holdings, Inc.(HRMY)92,0740-92,074$269.4K$0—-$269.4K
Janux Therapeutics, Inc.(JANX)49,8200-49,820$129.3K$0—-$129.3K
Mereo BioPharma Group plcADS(MREO)764,9010-764,901$167.3K$0—-$167.3K
Merus N.V.47,9990-47,999$479.8K$0—-$479.8K
Summit Therapeutics Inc.(SMMT)92,7370-92,737$203.4K$0—-$203.4K
Page 1 of 1